tiprankstipranks
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H (HK:3378)
:3378
Hong Kong Market
3378
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H
RESEARCH TOOLSreports

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H (3378) Financial Statements

― Followers

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H Financial Overview

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H's market cap is currently HK$3.73B. The company's EPS TTM is HK$0.12; its P/E ratio is 87.36; Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue¥ 25.69B¥ 17.69B¥ 13.93B¥ 12.92B¥ 12.92B
Gross Profit¥ 1.38B¥ 1.23B¥ 1.26B¥ 1.22B¥ 1.20B
Operating Income¥ 1.20B¥ 770.54M¥ 759.37M¥ 809.02M¥ 855.84M
EBITDA¥ 1.29B¥ 1.90B¥ 1.91B¥ 1.51B¥ 1.45B
Net Income¥ 769.11M¥ 616.58M¥ 668.76M¥ 554.39M¥ 819.60M
Balance Sheet
Cash & Short-Term Investments¥ 3.90B¥ 3.04B¥ 2.89B¥ 1.61B¥ 1.05B
Total Assets¥ 26.47B¥ 24.00B¥ 22.93B¥ 21.25B¥ 20.91B
Total Debt¥ 11.98B¥ 7.57B¥ 7.68B¥ 6.53B¥ 6.14B
Net Debt¥ 9.01B¥ 6.86B¥ 5.80B¥ 5.85B¥ 5.47B
Total Liabilities¥ 15.81B¥ 11.40B¥ 10.56B¥ 9.28B¥ 9.07B
Stockholders' Equity¥ 5.89B¥ 5.83B¥ 5.65B¥ 5.36B¥ 5.22B
Cash Flow
Free Cash Flow¥ 1.92B¥ 868.71M¥ 659.50M¥ 70.47M¥ 74.67M
Operating Cash Flow¥ 1.92B¥ 1.42B¥ 1.35B¥ 909.52M¥ 667.10M
Investing Cash Flow¥ -2.55B¥ -1.98B¥ -779.46M¥ -802.93M¥ -717.14M
Financing Cash Flow¥ 2.88B¥ -607.72M¥ 627.06M¥ -97.74M¥ -417.48M
Currency in CNY

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H Earnings and Revenue History

Income Statement >

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H Debt to Assets

Balance Sheet >

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H Cash Flow

Cash Flow >

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >